Balance Sheet Daiichi Life Group, Inc.

Stocks

8750

JP3476480003

Life & Health Insurance

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-07-17 EDT			5-day change	1st Jan Change
1,799.00 ^JPY	-2.04%		-3.33%	+38.01%

07-07	Japan asset managers pursue global investor mandates as yen bond demand grows	RE
06-28	Daiichi Life Wins Nod to Arrange Leveraged Buyout Loans as Japan M&A Surges	MT

e53807253a4a0e715.0Lyn1IE-tttsxo0TJ0NTT-KqjIMbM0iAa9dJgKyG02c.qvLxvdtPx6MBtuB_ciIQG5Cdw_RpfXy0HIMK5ZuwlR6dyOmj72fujQ_z7g

Published financial data: DAIICHI LIFE GROUP, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Premiums and Annuity Revenues	5,292B	6,635B	7,526B	6,796B	6,944B
Total Interest And Dividend Income	1,348B	1,362B	1,364B	1,531B	1,599B
Gain (Loss) on Sale of Investments, Total (Rev)	697B	591B	1,057B	925B	1,692B
Other Revenues, Total	367B	630B	468B	549B	629B
Total Revenues	7,704B	9,219B	10,416B	9,801B	10,864B
Policy Benefits	6,260B	6,638B	8,722B	7,096B	8,370B
Depreciation & Amortization - (IS) - (Collected)	13.46B	13.68B	14.04B	14.26B	14.83B
Selling General & Admin Expenses, Total	752B	831B	926B	990B	1,048B
Provision for Bad Debts	-	-	5.1B	-	-
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-459M	-1.51B	-4.39B	-6.56B	-3.06B
Other Operating Expenses	313B	588B	325B	358B	377B
Total Operating Expenses	7,339B	8,072B	9,996B	8,465B	9,813B
Operating Income	365B	1,147B	420B	1,337B	1,051B
Interest Expense, Total	-26.7B	-33B	-39.68B	-49.31B	-62.25B
Currency Exchange Gains (Loss)	453B	227B	539B	-127B	364B
Other Non Operating Income (Expenses)	-40.18B	-1M	-99.26B	-45.84B	-95.1B
EBT, Excl. Unusual Items	751B	1,341B	820B	1,115B	1,258B
Gain (Loss) on Sale of Investments	-247B	-1,025B	-368B	-496B	-612B
Gain (Loss) on Sale of Assets	-2.56B	-1.01B	20M	-7.05B	-3.54B
Asset Writedown	-3.85B	-15.94B	-5.31B	-2.24B	-10.06B
Other Unusual Items	-22.61B	-18.27B	-19.22B	-47.48B	-6.44B
EBT, Incl. Unusual Items	474B	281B	427B	562B	626B
Income Tax Expense	65.02B	88.38B	106B	133B	190B
Earnings From Continuing Operations	409B	192B	321B	430B	437B
Net Income to Company	409B	192B	321B	430B	437B
Minority Interest	-	-	-21M	-	-
Net Income - (IS)	409B	192B	321B	430B	437B
Net Income to Common Incl Extra Items	409B	192B	321B	430B	437B
Net Income to Common Excl. Extra Items	409B	192B	321B	430B	437B
Per Share Items
Net EPS - Basic	95.79	47.32	82.42	463.78	119.83
Basic EPS - Continuing Operations	95.79	47.32	82.42	463.78	119.83
Basic Weighted Average Shares Outstanding	4.27B	4.06B	3.89B	926M	3.64B
Net EPS - Diluted	95.74	47.3	82.4	463.72	119.82
Diluted EPS - Continuing Operations	95.74	47.3	82.4	463.72	119.82
Diluted Weighted Average Shares Outstanding	4.28B	4.07B	3.89B	926M	3.64B
Normalized Basic EPS	109.82	206.2	131.63	752.05	215.75
Normalized Diluted EPS	109.76	206.13	131.59	751.96	215.73
Dividend Per Share	20.75	21.5	28.25	-	54.5
Payout Ratio	16.78	44.1	26.28	37.79	35.91
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	455B	1,254B	519B	1,468B	1,197B
EBITA	370B	1,154B	429B	1,362B	1,084B
EBIT	365B	1,147B	420B	1,337B	1,051B
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	13.71	31.49	24.87	23.6	30.27
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	469B	838B	512B	697B	786B
Non-Cash Pension Expense	4.09B	8.85B	-8.01B	-15.82B	-23.42B
Supplemental Operating Expense Items
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Total Other Investments	51,504B	46,711B	51,839B	53,033B	55,576B
Total investments	51,504B	46,711B	51,839B	53,033B	55,576B
Cash And Equivalents	2,184B	1,619B	2,064B	1,889B	1,975B
Reinsurance Recoverable - (IS)	1,925B	1,659B	1,853B	2,048B	2,063B
Other Receivables - (Insurance Template)	4,714B	5,563B	5,665B	5,905B	5,774B
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	1,160B	1,240B	1,224B	1,273B	1,239B
Goodwill	56.24B	120B	115B	328B	302B
Other Intangibles, Total	447B	642B	593B	779B	661B
Restricted Cash	1,107B	911B	889B	899B	1,384B
Deferred Tax Assets Long-Term (Collected)	9.38B	248B	179B	171B	125B
Other Long-Term Assets, Total	2,775B	2,866B	3,118B	3,267B	5,059B
Total Assets	65,881B	61,579B	67,540B	69,593B	74,159B
Liabilities
Insurance And Annuity Liabilities	51,821B	52,930B	55,692B	58,134B	59,631B
Unpaid Claims	925B	1,017B	1,461B	1,432B	1,625B
Reinsurance Payable - (BS)	895B	598B	476B	302B	1,515B
Current Portion of Long-Term Debt	21.91B	8.07B	17.54B	39.79B	314B
Current Portion of Leases	-	-	-	-	-
Short-Term Borrowings	31.63B	43.06B	53.09B	41.94B	7.82B
Long-Term Debt	1,562B	1,556B	1,767B	1,987B	1,915B
Long-Term Leases	-	-	-	-	-
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	-
Pension & Other Post Retirement Benefits	393B	369B	213B	159B	19.91B
Deferred Tax Liability Non-Current	327B	115B	328B	168B	302B
Other Non Current Liabilities	5,496B	2,071B	3,651B	3,860B	4,577B
Total Liabilities	61,473B	58,706B	63,658B	66,123B	69,905B
Common Stock, Total	344B	344B	344B	344B	345B
Additional Paid In Capital	330B	330B	331B	331B	331B
Retained Earnings	1,335B	1,310B	1,215B	1,350B	1,611B
Treasury Stock	-12.72B	-13.92B	-17.26B	-9.94B	-16.95B
Comprehensive Income and Other	2,412B	903B	2,010B	1,455B	1,984B
Total Common Equity	4,409B	2,873B	3,882B	3,470B	4,254B
Minority Interest	-	1M	-	-	-
Total Equity	4,409B	2,873B	3,882B	3,470B	4,254B
Total Liabilities And Equity	65,881B	61,579B	67,540B	69,593B	74,159B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.1B	3.93B	3.78B	3.68B	3.6B
ECS Total Common Shares Outstanding	4.1B	3.93B	3.78B	3.68B	3.6B
Book Value / Share	1.08K	730.56	1.03K	942.59	1.18K
Tangible Book Value	3,906B	2,111B	3,174B	2,362B	3,291B
Tangible Book Value Per Share	953.11	536.88	839.47	641.79	913.86
Total Debt	1,615B	1,607B	1,838B	2,069B	2,237B
Net Debt	-569B	-11.66B	-227B	180B	262B
Debt Equivalent of Unfunded Proj. Benefit Obligation	393B	368B	212B	158B	19.35B
Minority Interest, Total (Incl. Fin. Div)	-	1M	-	-	-
Account Code - Inventory Valuation	-	-	-	-	-
Land - (BS)	-	-	-	-	-
Full Time Employees	62.26K	61K	59.5K	60.81K	60.14K

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	474B	281B	427B	562B	626B
Depreciation, Depletion & Amortization	84.81B	100B	89.44B	107B	113B
Amortization of Goodwill and Intangible Assets - (CF)	5.15B	7.03B	9.62B	25.23B	32.66B
Total Depreciation, Depletion & Amortization	89.96B	107B	99.06B	132B	146B
(Gain) Loss On Sale of Asset - (CF)	6.04B	16.44B	4.38B	3.34B	11.71B
(Gain) Loss on Sale of Investments - (CF)	-451B	432B	-669B	-431B	-1,002B
Total Asset Writedown	-	-	-	-	-
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-5.53B	-6.18B	-9.53B	-3.53B	-23.06B
Reinsurance Recoverable - (CF)	-	-	-	-	-
Reinsurance Payable - (CF)	-	-	-	-	-
Change in insurance Reserves / Liabilities	410B	-675B	1,713B	550B	1,992B
Change in Other Net Operating Assets (Collected)	-86.81B	438B	153B	-322B	-429B
Other Operating Activities	-899B	-725B	-721B	101B	-530B
Cash from Operations	-462B	-132B	997B	593B	792B
Capital Expenditure	-99.46B	-118B	-51.14B	-60.12B	-77.17B
Sale of Property, Plant, and Equipment	31.91B	56.55B	38.78B	47.01B	57.42B
Cash Acquisitions	-	-	-	-	-
Divestitures	-	-	-	-	-
Purchase / Sale of Intangible Assets	-48.85B	-43.82B	-38.69B	-44.35B	-42.59B
Investment in Marketable and Equity Securities, Total	474B	3,355B	-1,508B	-742B	-715B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-76.92B	-158B	-221B	-215B	144B
Other Investing Activities, Total	682B	-2,781B	1,178B	33.58B	-293B
Cash from Investing	963B	310B	-602B	-980B	-926B
Short Term Debt Issued, Total	110B	-	-	-	-
Long-Term Debt Issued, Total	111B	-	191B	316B	191B
Total Debt Issued	221B	-	191B	316B	191B
Short Term Debt Repaid, Total	-	-13.6B	-129B	-813M	-51.14B
Long-Term Debt Repaid, Total	-130B	-102B	-	-113B	-
Total Debt Repaid	-130B	-116B	-129B	-114B	-51.14B
Issuance of Common Stock	-	147M	-	-	-
Repurchase of Common Stock	-200B	-120B	-120B	-102B	-108B
Common Dividends Paid	-68.68B	-84.81B	-84.31B	-162B	-157B
Common & Preferred Stock Dividends Paid	-68.68B	-84.81B	-84.31B	-162B	-157B
Other Financing Activities, Total	-3.42B	-5.22B	-3.87B	-11.34B	-2.75B
Cash from Financing	-181B	-325B	-146B	-73.57B	-127B
Foreign Exchange Rate Adjustments	33.34B	48.02B	5.12B	2.61B	35.39B
Miscellaneous Cash Flow Adjustments	-1M	1M	-	1M	-
Net Change in Cash	354B	-99.46B	255B	-459B	-226B
Supplemental Items
Cash Interest Paid	32.08B	36.07B	42.71B	49.72B	58.23B
Cash Income Tax Paid (Refund)	141B	155B	-6.86B	102B	132B
Net Debt Issued / Repaid	91.39B	-116B	62.42B	202B	140B
Levered Free Cash Flow	-106B	917B	359B	510B	1,576B
Unlevered Free Cash Flow	-89.09B	938B	384B	541B	1,615B
Change In Net Working Capital	259B	-275B	-112B	322B	-932B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	0.35	1.12	0.41	1.22	0.91
Return on Total Capital	3	13.65	5.14	14.84	10.92
Return On Equity %	8.88	5.28	9.5	11.69	11.3
Return on Common Equity	8.88	5.28	9.5	11.69	11.3
Margin Analysis
Gross Profit Margin %	18.73	27.99	16.22	27.53	22.93
SG&A Margin	9.76	9.02	8.89	10.1	9.65
EBITDA Margin %	5.9	13.6	4.98	14.98	11.01
EBITA Margin %	4.8	12.51	4.12	13.89	9.97
EBIT Margin %	4.73	12.44	4.03	13.64	9.67
Income From Continuing Operations Margin %	5.31	2.09	3.08	4.38	4.02
Net Income Margin %	5.31	2.09	3.08	4.38	4.02
Net Avail. For Common Margin %	5.31	2.09	3.08	4.38	4.02
Normalized Net Income Margin	6.09	9.09	4.92	7.11	7.24
Levered Free Cash Flow Margin	-1.37	9.95	3.45	5.2	14.51
Unlevered Free Cash Flow Margin	-1.16	10.17	3.68	5.52	14.87
Asset Turnover
Asset Turnover	0.12	0.14	0.16	0.14	0.15
Fixed Assets Turnover	6.78	7.68	8.45	7.85	8.65
Short Term Liquidity
Current Ratio	2.39	2.12	2.09	2.24	1.44
Quick Ratio	1.07	0.89	0.97	0.93	0.55
Operating Cash Flow to Current Liabilities	-0.2	-0.06	0.41	0.26	0.2
Average Days Payable Outstanding	121.99	117.42	92.23	116.3	125.18
Long Term Solvency
Total Debt/Equity	36.64	55.95	47.34	59.64	52.57
Total Debt / Total Capital	26.82	35.88	32.13	37.36	34.46
LT Debt/Equity	35.43	54.17	45.52	57.28	45.02
Long-Term Debt / Total Capital	25.93	34.73	30.89	35.88	29.51
Total Liabilities / Total Assets	93.31	95.33	94.25	95.01	94.26
EBIT / Interest Expense	13.66	34.75	10.57	27.1	16.88
EBITDA / Interest Expense	17.03	38	13.07	29.78	19.22
(EBITDA - Capex) / Interest Expense	13.3	34.43	11.78	28.56	17.98
Total Debt / EBITDA	3.55	1.28	3.54	1.41	1.87
Net Debt / EBITDA	-1.25	-0.01	-0.44	0.12	0.22
Total Debt / (EBITDA - Capex)	4.55	1.41	3.93	1.47	2
Net Debt / (EBITDA - Capex)	-1.6	-0.01	-0.49	0.13	0.23
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	7.17	19.67	12.98	-5.9	10.84
Gross Profit, 1 Yr. Growth %	28.74	78.76	-34.51	59.72	-7.69
EBITDA, 1 Yr. Growth %	231.33	175.78	-58.64	183.15	-18.51
EBITA, 1 Yr. Growth %	444.3	211.93	-62.8	217.33	-20.43
EBIT, 1 Yr. Growth %	470.63	214.41	-63.42	218.59	-21.37
Earnings From Cont. Operations, 1 Yr. Growth %	12.53	-53.02	66.81	33.93	1.63
Net Income, 1 Yr. Growth %	12.53	-53.02	66.8	33.93	1.63
Normalized Net Income, 1 Yr. Growth %	57.96	78.56	-38.87	35.99	12.84
Diluted EPS Before Extra, 1 Yr. Growth %	17.69	-50.59	74.2	462.77	-74.16
Net Property, Plant and Equip., 1 Yr. Growth %	4.17	6.92	-1.25	3.98	-2.66
Total Assets, 1 Yr. Growth %	3.6	-6.53	9.68	3.04	6.56
Common Equity, 1 Yr. Growth %	-8.29	-34.83	35.12	-10.62	22.61
Tangible Book Value, 1 Yr. Growth %	-10.46	-45.94	50.31	-25.56	39.3
Cash From Operations, 1 Yr. Growth %	478.29	-71.33	-852.92	-40.59	33.68
Capital Expenditures, 1 Yr. Growth %	160.61	18.49	-56.61	17.55	28.37
Levered Free Cash Flow, 1 Yr. Growth %	405.41	-966.91	-60.87	42.06	209.16
Unlevered Free Cash Flow, 1 Yr. Growth %	1.15M	-1.15K	-59.08	40.92	198.73
Dividend Per Share, 1 Yr. Growth %	33.87	3.61	31.4	-	-
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.93	13.25	16.28	3.11	2.13
Gross Profit, 2 Yr. CAGR %	-9.12	51.7	8.2	2.27	21.43
EBITDA, 2 Yr. CAGR %	-21.38	202.28	6.8	8.21	51.9
EBITA, 2 Yr. CAGR %	-25.96	312.05	7.71	8.64	58.91
EBIT, 2 Yr. CAGR %	-26.29	323.57	7.25	7.96	58.28
Earnings From Cont. Operations, 2 Yr. CAGR %	255.27	-27.29	-11.48	49.47	16.66
Net Income, 2 Yr. CAGR %	255.27	-27.29	-11.48	49.47	16.67
Normalized Net Income, 2 Yr. CAGR %	135.08	67.94	4.48	-8.82	23.87
Diluted EPS Before Extra, 2 Yr. CAGR %	266.5	-23.75	-7.23	213.1	20.59
Net Property, Plant and Equip., 2 Yr. CAGR %	1.48	5.54	2.75	1.33	0.6
Total Assets, 2 Yr. CAGR %	4.78	-1.6	1.25	6.31	4.79
Common Equity, 2 Yr. CAGR %	8.04	-22.69	-6.16	9.89	4.68
Tangible Book Value, 2 Yr. CAGR %	8.73	-30.43	-9.86	5.78	1.83
Cash From Operations, 2 Yr. CAGR %	-11.51	28.76	46.92	111.5	-10.88
Capital Expenditures, 2 Yr. CAGR %	51.24	75.73	-28.3	-28.58	22.84
Levered Free Cash Flow, 2 Yr. CAGR %	-68.36	561.92	84.19	-25.44	109.57
Unlevered Free Cash Flow, 2 Yr. CAGR %	-70.58	34.68K	107.52	-24.07	105.17
Dividend Per Share, 2 Yr. CAGR %	15.7	17.78	16.68	-	38.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.73	10.32	13.16	8.36	5.62
Gross Profit, 3 Yr. CAGR %	-4.69	13.87	14.65	23.2	-1.16
EBITDA, 3 Yr. CAGR %	-9.81	19.46	55.76	47.81	-1.55
EBITA, 3 Yr. CAGR %	-12.68	19.58	84.84	54.41	-2.07
EBIT, 3 Yr. CAGR %	-12.86	19.54	87.23	54.17	-2.86
Earnings From Cont. Operations, 3 Yr. CAGR %	22.07	80.99	-4.11	1.62	31.43
Net Income, 3 Yr. CAGR %	22.07	80.99	-4.11	1.62	31.43
Normalized Net Income, 3 Yr. CAGR %	29.54	114.49	19.91	14.07	-2.11
Diluted EPS Before Extra, 3 Yr. CAGR %	25.38	87.92	0.43	69.2	36.32
Net Property, Plant and Equip., 3 Yr. CAGR %	0.42	3.26	3.22	3.16	-0.02
Total Assets, 3 Yr. CAGR %	5.6	0.86	2.03	1.84	6.39
Common Equity, 3 Yr. CAGR %	5.88	-8.71	-6.88	-7.67	13.98
Tangible Book Value, 3 Yr. CAGR %	6.11	-13.86	-10.06	-15.43	15.94
Cash From Operations, 3 Yr. CAGR %	-35.18	-39.22	131.97	8.65	81.51
Capital Expenditures, 3 Yr. CAGR %	19.58	39.43	10.24	-15.45	-13.17
Levered Free Cash Flow, 3 Yr. CAGR %	-32.36	-4.62	157.86	68.91	19.79
Unlevered Free Cash Flow, 3 Yr. CAGR %	-37.72	-3.06	3.57K	82.4	19.87
Dividend Per Share, 3 Yr. CAGR %	12.69	11.52	22.15	-	36.35
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.19	6.06	8.58	7.38	8.61
Gross Profit, 5 Yr. CAGR %	-1.45	7.93	0.27	9.08	17.32
EBITDA, 5 Yr. CAGR %	-2.83	11.54	-3.5	14.82	54.2
EBITA, 5 Yr. CAGR %	-4.21	11.48	-5.03	15.08	73.99
EBIT, 5 Yr. CAGR %	-4.32	11.48	-5.31	14.76	75.06
Earnings From Cont. Operations, 5 Yr. CAGR %	12.1	-11.98	7.35	67.66	3.72
Net Income, 5 Yr. CAGR %	12.1	-11.98	7.35	67.66	3.72
Normalized Net Income, 5 Yr. CAGR %	17.15	28.89	18.86	52.33	21.48
Diluted EPS Before Extra, 5 Yr. CAGR %	14.28	-9.43	11.15	130.5	8.05
Net Property, Plant and Equip., 5 Yr. CAGR %	0.37	1.86	1.35	2.48	2.17
Total Assets, 5 Yr. CAGR %	4.85	2.81	3.84	3.01	3.12
Common Equity, 5 Yr. CAGR %	7.04	-5.18	0.89	-1.68	-2.41
Tangible Book Value, 5 Yr. CAGR %	7.63	-8.73	-0.59	-6.49	-5.48
Cash From Operations, 5 Yr. CAGR %	-19.62	-35.31	-10.08	0.08	58.22
Capital Expenditures, 5 Yr. CAGR %	20.11	27.09	-2.54	6.69	15.12
Levered Free Cash Flow, 5 Yr. CAGR %	-6.95	41.23	0.98	-13.57	137.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-12.85	37.52	0.79	-12.08	1.06K
Dividend Per Share, 5 Yr. CAGR %	14.06	11.46	14.27	-	28.59